We are live on ! Find out more
CBMG

Cellular Biomedicine Group, Inc.
CBMG

Delisted

CBMG was delisted on the 19th of February, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in Cellular Biomedicine Group, Inc. in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 67 → 0 (-67)

100% less capital invested

Capital invested by funds: $80M → $0 (-$80M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 66

Holders
–
Holders Change
-67
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
66
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$16.1M
2
CS
Candriam SCA
Luxembourg
-$4.33M
3
HA
HHLR Advisors
Cayman Islands
-$4.32M
4
GCL
Glazer Capital LLC
New York
-$4.27M
5
State Street
State Street
Massachusetts
-$4.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
– -$16.1M -878,324 Closed
CS
2
Candriam SCA
Luxembourg
– -$4.33M -235,317 Closed
HA
3
HHLR Advisors
Cayman Islands
– -$4.32M -235,214 Closed
GCL
4
Glazer Capital LLC
New York
– -$4.27M -232,103 Closed
State Street
5
State Street
Massachusetts
– -$4.17M -226,658 Closed
Vanguard Group
6
Vanguard Group
Pennsylvania
– -$4.07M -221,371 Closed
Man Group
7
Man Group
United Kingdom
– -$3.9M -212,209 Closed
Northern Trust
8
Northern Trust
Illinois
– -$3.64M -197,896 Closed
Geode Capital Management
9
Geode Capital Management
Massachusetts
– -$3.47M -189,011 Closed
JP Morgan Chase
10
JP Morgan Chase
New York
– -$3.2M -174,264 Closed
Qube Research & Technologies (QRT)
11
Qube Research & Technologies (QRT)
United Kingdom
– -$2.55M -138,603 Closed
Morgan Stanley
12
Morgan Stanley
New York
– -$2.47M -134,401 Closed
AGM
13
Alpine Global Management
New York
– -$2.2M -119,902 Closed
PCM
14
Pentwater Capital Management
Florida
– -$2.02M -110,000 Closed
Russell Investments Group
15
Russell Investments Group
United Kingdom
– -$1.99M -108,545 Closed
Walleye Capital
16
Walleye Capital
New York
– -$1.93K -105,000 Closed
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
– -$1.53M -83,121 Closed
GCIA
18
Gabelli & Co Investment Advisers
New York
– -$1.21M -65,922 Closed
GF
19
Gabelli Funds
New York
– -$1.18M -64,143 Closed
OR
20
Olympiad Research
Connecticut
– -$1.01M -54,795 Closed
SMC
21
S. Muoio & Co
New York
– -$964K -52,468 Closed
Skandinaviska Enskilda Banken (SEB)
22
Skandinaviska Enskilda Banken (SEB)
Sweden
– -$852K -46,355 Closed
PPA
23
Parametric Portfolio Associates
Washington
– -$804K -43,748 Closed
N
24
Nuveen
North Carolina
– -$728K -39,571 Closed
Bank of New York Mellon
25
Bank of New York Mellon
New York
– -$629K -34,241 Closed
1
2 3

CBMG Hedge Fund Activity: Q1 2021 in Review

0 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Cellular Biomedicine Group, Inc. (CBMG) for Q1 2021, worth a combined $0 — down 100% from $80M a quarter earlier.

Sellers outnumbered buyers: 66 funds closed out of CBMG and 0 opened new positions — a net loss of 66 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $16.1M sold.

  • 0 institutional investors held Cellular Biomedicine Group, Inc. (CBMG) as of Q1 2021, down from 67 in Q4 2020.
  • Funds reported $0 of Cellular Biomedicine Group, Inc. stock for Q1 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Cellular Biomedicine Group, Inc. positions in Q1 2021 and 66 closed out, a net change of -66 holders.
  • The largest Cellular Biomedicine Group, Inc. seller in Q1 2021 was BlackRock, an estimated $16.1M sold.

Based on aggregated 13F filings for Q1 2021.